Moreover, the type of mutation present may be significant, especially in the case of BRCA2 for which patients with truncating mutations in the RAD15 binding domain had a survival advantage over individuals with other mutations in the same gene [ 75 ].
← all excerpts
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints.
1
—
—